Caremark Bulk Purchase Requirements
As 2022 comes to a close, we know that many pharmacies will make “bulk purchases” ahead of the new year in anticipation of price increases or to obtain wholesaler rebates.
Entries by Eric Hartkopf, PharmD
Authorized Distributors of OTC Diabetic Test Devices
Most pharmacies are familiar with the basic requirements of the Drug Supply Chain Security Act (DSCSA), including the requirement to purchase prescription products from authorized suppliers.
MounjaroTM Off-Label Use for Weight Loss Spells T-R-O-U-B-L-E
PAAS National® analysts have received many phone calls regarding prescriptions for MounjaroTM – in most cases the medication is suspected of being used “off-label” for weight loss.
Caremark Cease and Desist Letters – Trudhesa®
PAAS National® analysts have recently assisted a few pharmacies that received “Cease and Desist” Letters from Caremark related to dispensing Trudhesa® nasal spray for migraines.
Medicare Part D Long-Term Institutionalized (LTI) Resident Report
PAAS National® recently assisted numerous pharmacies that received an email communication from Express Scripts stating the pharmacy had inappropriately billed Part D claims while patients were in a qualified Part A stay.
Automatic Mailing for Part D Patients
Reminder tp pharmacies on some specific requirements when automatically mailing refills to Medicare Part D patients.
Medication Synchronization: Possible Concerns
See the tips below to ensure that your medication synchronization program will stand up to PBM scrutiny and keep you out of harm’s way.
Insulin Glargine (Winthrop) – Unbranded Biologic of Lantus®
Insulin glargine labeled by Winthrop U.S. came to market in May 2022, and with it a lot of additional confusion regarding pharmacy level substitution.
Who’s Initiating Your Audit – Plan Sponsor, PBM or Audit Contractor?
There are numerous entities that may initiate and perform pharmacy audits. While the actual audit process does not vary significantly, there are a few important nuances to understand.
Copays for Pharmacy Staff and Family
PAAS National® analysts occasionally field questions related to copay collection, particularly with respect to prescriptions for pharmacy employees and their families.
